TherapeuticsMD (TXMD) Operating Leases: 2019-2025
Historic Operating Leases for TherapeuticsMD (TXMD) over the last 6 years, with Sep 2025 value amounting to $5.4 million.
- TherapeuticsMD's Operating Leases fell 6.34% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 6.34%. This contributed to the annual value of $5.5 million for FY2024, which is 30.77% down from last year.
- As of Q3 2025, TherapeuticsMD's Operating Leases stood at $5.4 million, which was down 5.37% from $5.7 million recorded in Q2 2025.
- TherapeuticsMD's Operating Leases' 5-year high stood at $8.5 million during Q1 2021, with a 5-year trough of $5.4 million in Q3 2025.
- In the last 3 years, TherapeuticsMD's Operating Leases had a median value of $6.0 million in 2025 and averaged $6.4 million.
- As far as peak fluctuations go, TherapeuticsMD's Operating Leases rose by 8.63% in 2023, and later crashed by 30.77% in 2024.
- Quarterly analysis of 5 years shows TherapeuticsMD's Operating Leases stood at $8.1 million in 2021, then dropped by 8.61% to $7.4 million in 2022, then grew by 8.63% to $8.0 million in 2023, then plummeted by 30.77% to $5.5 million in 2024, then dropped by 6.34% to $5.4 million in 2025.
- Its Operating Leases was $5.4 million in Q3 2025, compared to $5.7 million in Q2 2025 and $6.0 million in Q1 2025.